A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Interchangeability of V114 and Prevnar 13™ With Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants (PNEU-DIRECTION)
Status: Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 20 Sep 2019
Price : $35 *
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary) ; Hib vaccine conjugate (Primary) ; Hib-DTaP-poliovirus vaccine (Primary) ; Measles mumps and rubella virus vaccine (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Rotavirus W179-9 vaccine (Primary) ; V 114 (Primary) ; Varicella zoster virus vaccine live (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions; Pharmacodynamics
- Acronyms PNEU-DIRECTION
- Sponsors Merck Sharp & Dohme
- 18 Sep 2019 Planned End Date changed from 3 Mar 2021 to 11 Dec 2020.
- 18 Sep 2019 Planned primary completion date changed from 3 Mar 2021 to 11 Dec 2020.
- 02 Aug 2019 Planned End Date changed from 6 Aug 2020 to 3 Mar 2021.